Kevin Young, EVP, Commercial Operations at GILEAD SCIENCES INC (GILD), sold 30,000 shares at $51.50 ($1.5M) on 2008-04-10, disclosed to the SEC on 2008-04-14.
Scheduled sale ($1.5M) by EVP, Commercial Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.50 | 12,500 | $644K | 41.7% |
| 2 | $51.51 | 8,200 | $422K | 27.3% |
| 3 | $51.52 | 5,500 | $283K | 18.3% |
| 4 | $51.60 | 3,800 | $196K | 12.7% |
| Total | $51.52 avg | 30,000 | $1.5M | 100% |
| Filing → |
| GILD | SELL | 2013-12-24 | $5.6M | — | Filing → |
| GILD | SELL | 2013-11-25 | $5.6M | — | Filing → |
| GILD | SELL | 2013-10-25 | $5.1M | — | Filing → |